Hi. I was diagnosed with primary breast cancer in January 2013 - with a 4 cm tumour, lymph node involvement and dcis. Lymph nodes were diagnosed with fine needle aspirant. I had neo adjuvant chemo (ec and taxol - 4 cycles of each) wide local excision and level 1 axillary clearance. My pathology report showed only 2mm of invasive cancer left. And no cancer in the lymph nodes. So in having radiotherapy - the royal marsden in London did not plan to give radiotherapy to the supraclavicular fossa. They did not mention this but I queried it and they said it was my choice. As I had neoadjuvant chemo it's impossible to know how many lymph nodes were involved. The policy is if you have 4 or more nodes they offer scf. With ppl in my situation it's not routinely offered. Should I have it? Risks appear to be lymphodemia, nerve damage (1% risk) , slightly mor lung tissue exposed. Are there risks to the oesphogus or thyroid?? My risk of a recurrence, in the scf is low (around 3-5%), is there any evidence to help me make this decision?? I understand the us is launching trials on how to treat those who present node positive and convert to node negative. Thanks my cancer was left sided and her 2 positive - I'm receiving herceptin.
Wed, 10/02/2013 - 11:48#1
Should I have radiotherapy to the supraclavicular fossa - 1259606